Literature DB >> 4852110

Functional studies of the parotid and pancreas glands in amyotrophic lateral sclerosis.

R J Charchaflie, L Bustos Fernandez, C J Perec, E Gonzalez, A Marzi.   

Abstract

Functional studies of the pancreas and parotid glands are reported in 17 patients with amyotrophic lateral sclerosis (ALS). The exocrine function of the pancreas was studied by measuring amylase concentration after stimulation with the endogenous secretin-pancreozymine test (ESP). Under these conditions, the pancreatic amylase concentration in ALS patients was found to be markedly decreased by about 45% when compared with those of healthy control subjects. Different conclusions in the literature about a possible impairment of the exocrine pancreas in ALS patients induced us to study the function of the parotid gland, which has close structural, functional, and physiopathological relationship with the pancreas. Flow rate and bicarbonate concentration of parotid saliva were measured after indirect stimulation (intraoral citric acid) and direct stimulation (pilocarpine). After indirect stimulation, both parotid flow rate and bicarbonate concentration from ALS patients were found to be decreased by about 66% and 70% respectively, when compared with controls. On the other hand, direct stimulation with pilocarpine in ALS patients elicited normal responses in both flow rate and bicarbonate concentration of saliva. It is concluded that the pancreatic and parotid deficiencies observed in ALS patients do not indicate primary disease of these exocrine glands. This interpretation is further emphasized by the results obtained by a sweat test, plasma osmolarity, and sialographic studies. The possibility that the gland impairments observed might be due to modifications of the neuroendocrine mechanisms regulating their secretory activity is suggested.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4852110      PMCID: PMC494795          DOI: 10.1136/jnnp.37.7.863

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Modified Carlson-Crittenden device for the collection of parotid fluid.

Authors:  I L SHANNON; J R PRIGMORE; H H CHAUNCEY
Journal:  J Dent Res       Date:  1962 Jul-Aug       Impact factor: 6.116

2.  Parotid swelling alcoholism and cirrhosis.

Authors:  S J WOLFE; W H SUMMERSKILL; C S DAVIDSON
Journal:  N Engl J Med       Date:  1957-03-14       Impact factor: 91.245

3.  Enlargement of the parotid gland in disease of the liver.

Authors:  E N ROTHBELL; J J DUGGAN
Journal:  Am J Med       Date:  1957-03       Impact factor: 4.965

4.  Amyotrophic lateral sclerosis observed in 5 persons after gastric resection.

Authors:  E ASK-UPMARK
Journal:  Gastroenterology       Date:  1950-06       Impact factor: 22.682

5.  Laboratory diagnostic test for pancreatic disorders by examination of parotid saliva.

Authors:  G Kakizaki; N Noto; T Saito; Y Fujiwara; T Oizumi
Journal:  Tohoku J Exp Med       Date:  1973-02       Impact factor: 1.848

6.  Exocrine pancreatic function in patients with amyotrophic lateral sclerosis.

Authors:  G McEwan-Alvarado; N C Hightower; L R Carney; C W Barrier
Journal:  Am J Dig Dis       Date:  1971-02

7.  The parotid gland in subjects with and without rheumatoid arthritis. A sialographic and physiologic study.

Authors:  S Ericson
Journal:  Acta Radiol Diagn (Stockh)       Date:  1968

8.  Pancreatic dysfunction in patients with amyotrophic lateral sclerosis.

Authors:  D T Quick; M Greer
Journal:  Neurology       Date:  1967-02       Impact factor: 9.910

9.  A comparison of Boots and GIH secretin as stimuli of pancreatic secretion in human subjects with or without chronic pancreatitis.

Authors:  L V Gutierrez; J H Baron
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

  9 in total
  4 in total

1.  Management of symptoms in amyotrophic lateral sclerosis.

Authors:  Lisa S Thibodeaux; Amparo Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

2.  [Amyotrophic lateral sclerosis: management of bulbar symptoms].

Authors:  P Kraft; M Beck; A Grimm; C Wessig; K Reiners; K V Toyka
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

3.  Morphological changes of parotid gland in experimental hyperlipidemia.

Authors:  Ioanna D Daskala; Christina C Tesseromatis
Journal:  Int J Dent       Date:  2011-03-21

Review 4.  A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men.

Authors:  Sarah Martin; Carolina Battistini; Jun Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-03-11       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.